Pre-earnings options volume in Maravai LifeSciences (MRVI) is 4.3x normal with calls leading puts 36:1. Implied volatility suggests the market is anticipating a move near 16.5%, or 0c, after results are released. Median move over the past eight quarters is 12.1%.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVI:
- May 05, 2025 Deadline: Contact Levi & Korsinsky LLP to Join Class Action Suit Against MRVI
- Hold Rating on Maravai Lifesciences Due to Filing Delays and Financial Reporting Concerns
- Maravai LifeSciences Delays 2024 Annual Report Filing
- Maravai Lifesciences price target lowered to $8 from $9 at BofA
- Biotech Alert: Searches spiking for these stocks today